Stephens Inc. AR Has $1.32 Million Stake in Colgate-Palmolive (NYSE:CL)

Stephens Inc. AR boosted its holdings in Colgate-Palmolive (NYSE:CL) by 21.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,506 shares of the company’s stock after buying an additional 2,555 shares during the period. Stephens Inc. AR’s holdings in Colgate-Palmolive were worth $1,319,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Creative Planning raised its position in shares of Colgate-Palmolive by 2.0% in the 3rd quarter. Creative Planning now owns 218,018 shares of the company’s stock valued at $22,632,000 after acquiring an additional 4,372 shares during the period. Occidental Asset Management LLC raised its holdings in Colgate-Palmolive by 25.1% in the third quarter. Occidental Asset Management LLC now owns 3,579 shares of the company’s stock worth $372,000 after purchasing an additional 719 shares during the period. NBC Securities Inc. boosted its position in shares of Colgate-Palmolive by 49.3% during the third quarter. NBC Securities Inc. now owns 5,463 shares of the company’s stock worth $567,000 after purchasing an additional 1,804 shares in the last quarter. Swedbank AB grew its holdings in shares of Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after buying an additional 40,324 shares during the period. Finally, Capstone Wealth Management Group LLC increased its position in shares of Colgate-Palmolive by 3.2% in the 3rd quarter. Capstone Wealth Management Group LLC now owns 9,520 shares of the company’s stock valued at $988,000 after buying an additional 292 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 0.7 %

Shares of NYSE:CL opened at $86.75 on Thursday. The company has a 50-day simple moving average of $90.00 and a 200 day simple moving average of $96.61. The company has a market capitalization of $70.88 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. Colgate-Palmolive has a 52-week low of $82.76 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 earnings per share. Sell-side analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analysts Set New Price Targets

Several research firms have weighed in on CL. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average price target of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.